SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Trading Up 1.1% – Still a Buy?

Posted by Amy Steele on Feb 18th, 2026

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report) traded up 1.1% during mid-day trading on Tuesday . The company traded as high as $57.88 and last traded at $57.49. 166,813 shares changed hands during trading, an increase of 21% from the average session volume of 137,326 shares. The stock had previously closed at $56.84.

SPDR S&P Pharmaceuticals ETF Price Performance

The company’s 50 day simple moving average is $56.41 and its 200 day simple moving average is $51.31. The stock has a market cap of $298.95 million, a P/E ratio of 14.28 and a beta of 0.60.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Envestnet Portfolio Solutions Inc. increased its stake in SPDR S&P Pharmaceuticals ETF by 6.7% during the 3rd quarter. Envestnet Portfolio Solutions Inc. now owns 171,930 shares of the company’s stock worth $8,242,000 after purchasing an additional 10,842 shares in the last quarter. Advantage Trust Co lifted its stake in SPDR S&P Pharmaceuticals ETF by 1,525.0% in the second quarter. Advantage Trust Co now owns 3,250 shares of the company’s stock valued at $132,000 after buying an additional 3,050 shares in the last quarter. Park Avenue Securities LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF in the third quarter valued at approximately $485,000. Compass Wealth Management LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF during the fourth quarter worth $992,000. Finally, EP Wealth Advisors LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the second quarter worth $278,000.

SPDR S&P Pharmaceuticals ETF Company Profile

(Get Free Report)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.